AZN icon

AstraZeneca

82.03 USD
+0.31
0.38%
At close Updated Nov 4, 4:00 PM EST
Pre-market
After hours
82.30
+0.27
0.33%
1 day
0.38%
5 days
-1.63%
1 month
-4.05%
3 months
9.97%
6 months
13.79%
Year to date
24.51%
1 year
14.84%
5 years
49.04%
10 years
155.31%
 

About: A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Employees: 94,300

0
Funds holding %
of 7,507 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™